JCI-20679 Suppresses the Proliferation of Glioblastoma Stem Cells by Activating AMPK and Decreasing NFATc2 Expression Levels

Scientists demonstrated that JCI‑20679 inhibited the growth of glioblastoma stem cells derived from a transposon system‑mediated murine glioblastoma model more efficiently compared with the growth of differentiation‑induced adherent cells.